Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence J Saubermann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Immunological Reviews|February 13, 2007
Repertoire of the alpha beta T-cell receptor in the intestineChristopher S J Probert, Lawrence J Saubermann, Steven Balk, et al.
Journal of Immunotoxicology|January 4, 2013
Neither direct nor developmental exposure to bisphenol A alters the severity of experimental inflammatory colitis in miceAnirban Roy, Alison Gaylo, Wenqing Cao, et al.
Case Reports in Gastroenterology|February 5, 2025
Successful Pregnancy in a Patient with Crohn's Disease and Short Bowel Syndrome: Off Total Parenteral Nutrition and On Teduglutide, a Glucagon-Like Peptide-2 Analog - A Case ReportMaria M Dahar, MacKenzie Both, Linda M Lord, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 18, 2006
Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosisKleanthis G Dendrinos, James M Becker, Arthur F Stucchi, et al.
International Journal of Cancer|November 11, 2006
PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cellsKatherine L Schaefer, Hirokazu Takahashi, Victor M Morales, et al.
Inflammatory Bowel Diseases|March 1, 2005
Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanismsKatherine L Schaefer, Svetlana Denevich, Chen Ma, et al.
Inflammatory Bowel Diseases|December 14, 2002
Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitisLawrence J Saubermann, Atsushi Nakajima, Koichiro Wada, et al.
Mutagenesis|February 13, 2020
Dextran sulfate sodium mouse model of inflammatory bowel disease evaluated for systemic genotoxicity via blood micronucleus and Pig-a gene mutation assaysChristopher Kirby, Ayesha Baig, Svetlana L Avlasevich, et al.
Environmental and Molecular Mutagenesis|August 8, 2020
Assessment of systemic genetic damage in pediatric inflammatory bowel diseaseAyesha Baig, Svetlana L Avlasevich, Dorothea K Torous, et al.
Cancer Research|March 23, 2005
Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cellsKatherine L Schaefer, Koichiro Wada, Hirokazu Takahashi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Immunological Reviews|February 13, 2007
Repertoire of the alpha beta T-cell receptor in the intestineChristopher S J Probert, Lawrence J Saubermann, Steven Balk, et al.
Journal of Immunotoxicology|January 4, 2013
Neither direct nor developmental exposure to bisphenol A alters the severity of experimental inflammatory colitis in miceAnirban Roy, Alison Gaylo, Wenqing Cao, et al.
Case Reports in Gastroenterology|February 5, 2025
Successful Pregnancy in a Patient with Crohn's Disease and Short Bowel Syndrome: Off Total Parenteral Nutrition and On Teduglutide, a Glucagon-Like Peptide-2 Analog - A Case ReportMaria M Dahar, MacKenzie Both, Linda M Lord, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 18, 2006
Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosisKleanthis G Dendrinos, James M Becker, Arthur F Stucchi, et al.
International Journal of Cancer|November 11, 2006
PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cellsKatherine L Schaefer, Hirokazu Takahashi, Victor M Morales, et al.
Inflammatory Bowel Diseases|March 1, 2005
Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanismsKatherine L Schaefer, Svetlana Denevich, Chen Ma, et al.
Inflammatory Bowel Diseases|December 14, 2002
Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitisLawrence J Saubermann, Atsushi Nakajima, Koichiro Wada, et al.
Mutagenesis|February 13, 2020
Dextran sulfate sodium mouse model of inflammatory bowel disease evaluated for systemic genotoxicity via blood micronucleus and Pig-a gene mutation assaysChristopher Kirby, Ayesha Baig, Svetlana L Avlasevich, et al.
Environmental and Molecular Mutagenesis|August 8, 2020
Assessment of systemic genetic damage in pediatric inflammatory bowel diseaseAyesha Baig, Svetlana L Avlasevich, Dorothea K Torous, et al.
Cancer Research|March 23, 2005
Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cellsKatherine L Schaefer, Koichiro Wada, Hirokazu Takahashi, et al.
Pageof 2